scholarly journals Low-Dose Lenalidomide after Non-Myeloablative Allogeneic Hematopoietic Cell Transplant with Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma

2018 ◽  
Vol 24 (3) ◽  
pp. S335
Author(s):  
Jack Khouri ◽  
Fred Reu ◽  
Navneet S. Majhail ◽  
Aaron T. Gerds ◽  
Deepa Jagadeesh ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document